Schedule 13D ownership disclosure

Climb Bio, Inc.

Common Stock, par value $0.0001 per share · CUSIP: 28658R106

Event date: 2026-11-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.Reported CIK 0001346824

    Shares: 23,941,277.00 · Class: 33.0%

  • Peter KolchinskyReported CIK 0001384859

    Shares: 23,941,277.00 · Class: 33.0%

  • Rajeev ShahReported CIK 0001619841

    Shares: 23,941,277.00 · Class: 33.0%

  • RA Capital Healthcare Fund, L.P.Reported CIK 0001315082

    Shares: 17,693,174.00 · Class: 24.4%

  • RA Capital Nexus Fund III, L.P.Reported CIK 0001883840

    Shares: 3,679,649.00 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001346824-26-000257
Form type
SCHEDULE 13D/A
Filer
Climb Bio, Inc.
CIK
CIK 1768446
Filed
Nov 09, 2026
Reporting period
Nov 05, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub